Savill Corrine's Form 4 filing
Cullinan Therapeutics, Inc. (CGEM) · filed Jan 24, 2024
- Accession no.
- 0000950170-24-007032
- Filed
- Jan 24, 2024
- Trade date
- Jan 22-23, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $492.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Savill CorrineCIK 0001837524 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | Common Stock | MOption exerciseAcquired | +14,559 | $4.30 | +$62,603.7 | 184,674 | Direct | |
| Jan 22, 2024 | Common Stock | SSaleDisposed | −14,559 | $12.18 | −$177,328.62 | 170,115 | Direct | |
| Jan 22, 2024 | Common Stock | SSaleDisposed | −4,125 | $12.02 | −$49,582.5 | 165,990 | Direct | |
| Jan 23, 2024 | Common Stock | MOption exerciseAcquired | +21,316 | $4.30 | +$91,658.8 | 187,306 | Direct | |
| Jan 23, 2024 | Common Stock | SSaleDisposed | −21,316 | $12.46 | −$265,597.36 | 165,990 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | Common Stock | MOption exerciseDisposed | −14,559 | $0.00 | $0 | 35,313 | Direct | |
| Jan 23, 2024 | Common Stock | MOption exerciseDisposed | −21,316 | $0.00 | $0 | 13,997 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.